by Sue Robbins | Aug 20, 2020 | Migraine
Predictors of chronic migraine Recent data from a systematic review and meta-analysis point to clinical and sociodemographic factors associated with migraine chronification INTERNATIONAL HEADACHE SOCIETY London, UK: A meta-analysis published in the...
by Sue Robbins | Aug 18, 2020 | Migraine
When Jennifer Latson began having migraines at 12, she wasn’t sure exactly what was going on. She just knew she felt terrible. “I would be out sick for a day or two each month,” she said. “It was intense pain, and it made me puke constantly.” Her parents...
by Sue Robbins | Aug 13, 2020 | Migraine
I was sitting in my neurologist’s office, as my doctor and I reviewed the long list of things we’d already tried to treat my chronic migraine—supplements and hard-to-pronounce drugs, abortive and preventative medications, near-misses and...
by Sue Robbins | Jul 30, 2020 | Migraine
Phase 3 ADVANCE trial evaluating atogepant meets primary endpoint of statistically significant reduction from baseline in mean monthly migraine days, compared to placebo, for all doses evaluated across a 12-week treatment period – Trial also...
by Sue Robbins | Jul 28, 2020 | Migraine
In patients with episodic migraine, erenumab provided sustained efficacy for the condition over the course of 1 year, according to new results from a study to evaluate the efficacy and safety of erenumab in migraine prevention (STRIVE), published in Neurology....
